High myopia, generally defined as near-sightedness of =-6.0 diopters or axial length of = 26.5 mm, is one of the major causes of visual impairment throughout the world, especially in Asia. By 2050, about 928 million people are expected to have high myopia, nearly 10% of the total population. High myopia is characterized by severe axial length elongation, and induces various complications including cataract formation, myopic macular degeneration, staphyloma, myopic glaucoma, and more. Inappropriate management of high myopia and related complications could lead to poor prognosis in these patients.
Nowadays, many surgical advancements could better deal with these issues. Many new aspects of highly myopic eyes could be better elucidated, including morphological and structural aspects based on fundus photography or optical coherence tomography, preoperative biometry and intraocular lens power calculation, application of multifocal intraocular lenses, and prevention and treatment of complications such as myopic choroidal neovascularization, myopic foveoschisis, myopic macular hole detachments, myopic glaucoma, capsular contraction syndrome, etc. Mechanistic investigation of progression in high myopia related complications is also necessary.
Therefore, with the growing prevalence and complications of high myopia, a better understanding of prevention, management, and treatment approaches of high myopia and its complications are of utmost importance. This Research Topic aims to bring together a comprehensive source of articles highlighting recent advances in epidemiology, pathological mechanisms, and novel discoveries on the management and treatment of high myopia and its complications. We would also like to bring attention to major trends and challenges in this ongoing epidemic.
We welcome Original Research focusing on, but not limited to, the following aspects:
1. Epidemiological study of high myopia and its complications, including but not limited to highly myopic cataract, myopic retinopathy and glaucoma
2. New insights into the pathogenesis of high myopia and its complications with the application of advanced technology and modern molecular-biological investigation
3. Novel discoveries on the management of high myopia and its complications, including but not limited to cataract surgeries, retina surgeries, and anti-vascular endothelial growth factor drugs administration
*Abstract submission is optional
High myopia, generally defined as near-sightedness of =-6.0 diopters or axial length of = 26.5 mm, is one of the major causes of visual impairment throughout the world, especially in Asia. By 2050, about 928 million people are expected to have high myopia, nearly 10% of the total population. High myopia is characterized by severe axial length elongation, and induces various complications including cataract formation, myopic macular degeneration, staphyloma, myopic glaucoma, and more. Inappropriate management of high myopia and related complications could lead to poor prognosis in these patients.
Nowadays, many surgical advancements could better deal with these issues. Many new aspects of highly myopic eyes could be better elucidated, including morphological and structural aspects based on fundus photography or optical coherence tomography, preoperative biometry and intraocular lens power calculation, application of multifocal intraocular lenses, and prevention and treatment of complications such as myopic choroidal neovascularization, myopic foveoschisis, myopic macular hole detachments, myopic glaucoma, capsular contraction syndrome, etc. Mechanistic investigation of progression in high myopia related complications is also necessary.
Therefore, with the growing prevalence and complications of high myopia, a better understanding of prevention, management, and treatment approaches of high myopia and its complications are of utmost importance. This Research Topic aims to bring together a comprehensive source of articles highlighting recent advances in epidemiology, pathological mechanisms, and novel discoveries on the management and treatment of high myopia and its complications. We would also like to bring attention to major trends and challenges in this ongoing epidemic.
We welcome Original Research focusing on, but not limited to, the following aspects:
1. Epidemiological study of high myopia and its complications, including but not limited to highly myopic cataract, myopic retinopathy and glaucoma
2. New insights into the pathogenesis of high myopia and its complications with the application of advanced technology and modern molecular-biological investigation
3. Novel discoveries on the management of high myopia and its complications, including but not limited to cataract surgeries, retina surgeries, and anti-vascular endothelial growth factor drugs administration
*Abstract submission is optional